logo

For the Inventor, By the Inventor

Givataym, Israel

Sharon Avhar-Maydan

USPTO Granted Patents = 9 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 37(Granted Patents)


Company Filing History:

goldMedal9 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents

Years Active: 2006-2012

Loading Chart...
9 patents (USPTO):Explore Patents
1. 8283487 - Processes for the preparation and purification of gabapentin enacarbil (2012-10-09),
2. 7687642 - Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them (2010-03-30),
3. 7563930 - Crystal forms of Cinacalcet HCI and processes for their preparation (2009-07-21),
4. 7462738 - Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof (2008-12-09),
5. 7414140 - Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them (2008-08-19),
6. 7368606 - Amorphous cinacalcet hydrochloride and preparation thereof (2008-05-06),
7. 7250533 - Process for preparing Cinacalcet hydrochloride (2007-07-31),
8. 7247751 - Processes for preparing cinacalcet hydrochloride crystal Form I (2007-07-24),
9. 7074928 - Polymorphs of clopidogrel hydrogensulfate (2006-07-11),

Title: The Innovative Mind of Inventor Sharon Avhar-Maydan

Introduction:

Sharon Avhar-Maydan is a brilliant inventor hailing from Givataym, Israel, with a remarkable portfolio of 9 patents to her name. Her latest patents showcase her expertise in the pharmaceutical industry, particularly in processes for the preparation and purification of gabapentin enacarbil and fluvastatin sodium crystal forms.

Latest Patents:

One of Sharon Avhar-Maydan's recent patents involves the innovative processes for the preparation and purification of gabapentin enacarbil. This includes the synthesis of intermediates such as 1-haloalkyl carbamate or carbonate and diacid acetal skeleton, showcasing her intricate knowledge of pharmaceutical chemistry.

Another noteworthy patent of Sharon Avhar-Maydan is related to fluvastatin sodium crystal forms. She has developed unique crystalline forms of fluvastatin sodium and detailed processes for their preparation, contributing to advancements in pharmaceutical technology.

Career Highlights:

Sharon Avhar-Maydan is an invaluable asset to Teva Pharmaceutical Industries Limited, where she applies her inventive skills to drive forward groundbreaking pharmaceutical solutions. Her dedication to innovation has led to the development of key patents that have the potential to revolutionize the pharmaceutical landscape.

Collaborations:

In her professional journey, Sharon Avhar-Maydan has collaborated closely with esteemed colleagues such as Revital Lifshitz-Liron and Shlomit Wizel. Together, they have worked on intricate projects, exchanging knowledge and expertise to push the boundaries of pharmaceutical innovation.

Conclusion:

In conclusion, Sharon Avhar-Maydan stands out as a pioneering inventor in the field of pharmaceuticals, with a demonstrated track record of success in patenting innovative processes and formulations. Her contributions to Teva Pharmaceutical Industries Limited and the broader scientific community highlight her as a trailblazer in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…